Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.491 USD | +0.53% | -6.95% | -62.30% |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.30% | 26.81M | |
-2.64% | 102B | |
+3.11% | 96.07B | |
-1.22% | 21.66B | |
-18.28% | 20.77B | |
-7.15% | 18.53B | |
-40.31% | 16.91B | |
-28.43% | 13.79B | |
+0.72% | 13.33B | |
+21.66% | 10.94B |
- Stock Market
- Equities
- BIVI Stock
- News BioVie Inc.
- BioVie : Obtains FDA Guidance for Phase 3 Clinical Study of BIV201 in Hepatorenal Syndrome-Acute Kidney Injury Treatment